Interaction of synthetic peptides corresponding to hepatitis G virus (HGV/GBV-C) E2 structural protein with phospholipid vesicles by Larios, Cristina et al.
Interaction of synthetic peptides corresponding
to hepatitis G virus (HGV/GBV-C) E2 structural protein
with phospholipid vesicles
Cristina Larios1,2, Bart Christiaens3, M. Jose´ Go´mara1, M. Asuncio´n Alsina2 and Isabel Haro1
1 Department of Peptide and Protein Chemistry, IIQAB-CSIC, Barcelona, Spain
2 Associated Unit CSIC, Department of Physical Chemistry, Faculty of Pharmacy, University of Barcelona, Spain
3 Laboratory of Lipoprotein Chemistry, Department of Biochemistry, Ghent University, Belgium
The hepatitis G virus (HGV) and the GB virus C
(GBV-C) are strain variants of a recently discovered
enveloped RNA virus belonging to the Flaviviridae
family, which is transmitted by contaminated blood
and ⁄or blood products, intravenous drug use, from
mother to child and by sexual intercourse. The natural
history of HGV ⁄GBV-C infection is not fully under-
stood, and its potential to cause hepatitis in humans
is questionable [1]. Moreover, the mode of entry of
HGV ⁄GBV-C into target cells is not known.
Elucidation of the mechanism of the fusion of envel-
oped viruses with target membranes has attracted
considerable attention because of its relative simplicity
and potential clinical importance. Apart from the
functions of viral binding to target membranes and
the activation of viral fusion proteins, usually only one
viral protein is responsible for the actual membrane
fusion step. However, the nature of the interaction of
viral fusion proteins with membranes and the mechan-
ism by which these proteins accelerate the formation
of membrane fusion intermediates are poorly under-
stood [2]. In this sense, specialized hydrophobic
conserved domains (‘fusion peptides’) have been
postulated to be absolutely required for the fusogenic
activity [3,4].
The envelope proteins (E) of ﬂaviviruses have been
described as class II fusion proteins that have struc-
tural features that set them apart from the well-known
rod-like ‘spikes’ of inﬂuenza virus or HIV. They are pre-
dominantly nonhelical, having instead a b-sheet-type
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The interaction with phospholipid bilayers of two synthetic peptides with
sequences corresponding to a segment next to the native N-terminus and
an internal region of the E2 structural hepatitis G virus (HGV ⁄GBV-C)
protein [E2(7–26) and E2(279–298), respectively] has been characterized.
Both peptides are water soluble but associate spontaneously with bilayers,
showing higher afﬁnity for anionic than zwitterionic membranes. However,
whereas the E2(7–26) peptide is hardly transferred at all from water to the
membrane interface, the E2(279–298) peptide is able to penetrate into neg-
atively charged bilayers remaining close to the lipid ⁄water interface. The
nonpolar environment clearly induces a structural transition in the
E2(279–298) peptide from random coil to a-helix, which causes bilayer
perturbations leading to vesicle permeabilization. The results indicate that
this internal segment peptide sequence is involved in the fusion of
HGV ⁄GBV-C to membrane.
Abbreviations
E, envelope proteins; HCV, hepatitis C virus; HGV ⁄GBV-C, hepatitis G virus; LUV, large unilamellar vesicle; PamOlePtdCho, 1-palmitoyl-
2-oleoylphosphatidylcholine; PamOlePtdGro, 1-palmitoyl-2-oleoylphosphatidylglycerol; SUV, small unilamellar vesicle; TBEV, tick-borne
encephalitis virus.
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structure; they are not cleaved during biosynthesis and
appear to have fusion peptides within internal loop
structures, distant from the N-terminus [5]. The only
protein of this class for which a high-resolution struc-
ture is available is the envelope glycoprotein E of
the ﬂavivirus tick-borne encephalitis virus (TBEV) [6].
It has been proposed that a highly conserved loop at
the tip of each subunit of the ﬂavivirus E protein
(sequence element containing amino acids 98–110 of
the ﬂavivirus E protein) may serve as an internal
fusion peptide, as it is directly involved in interactions
with target membranes during the initial stages of
membrane fusion [7]. Because of the structural homol-
ogy, extrapolating knowledge from the TBEV structure
to hepatitis C virus (HCV) leads to the idea that E2
may be the fusion protein. Although very little is
known about the HCV cell fusion process, sequence
alignment between the TBEV E protein and the HCV
E2 protein suggests that residues 476–494 in E2 may
play a role in viral fusion [8]. As HGV ⁄GBV-C is the
most closely related human virus to HCV [9], it can be
expected that E2 sequences of these related viruses are
functionally equivalent, and therefore conserve some
structural similarity. However, owing to the low pair-
wise sequence identity with HCV E2 (< 20%),
attempts to align these sequences using sequence infor-
mation and ⁄or through their predicted secondary
structure have been unsuccessful and have given
ambiguous results [8].
Besides, experimental information on the type of
interactions established by internal fusion peptides
with membranes is at present limited. Predictive struc-
tural analyses indicate that internal fusion peptides are
segmented into two regions separated by a putative
turn or loop, which usually contains one or more Pro
residues. This organization seems to be fundamental to
the fusogenic function [10]. It has been shown that Pro
residues display the highest propensity for turn induc-
tion at the membrane interface in poly(Leu) stretches
[11,12] and therefore play important structural roles
in membrane-inserted peptide chains [13].
The direct involvement of fusion peptides in virus–cell
fusion is supported by studies using model membranes,
membrane mimetic systems, and synthetic peptide
fragments representing functional and nonfunctional
fusion peptide sequences, which demonstrate that, after
insertion, only functional sequences generate target-
membrane perturbations [4].
In this study, we report on the interaction of an
N-terminal (E2(7–26)) and an internal (E2(279–298))
synthetic peptide sequence of the E2 structural pro-
tein of HGV ⁄GBV-C with phospholipid membranes
of different composition. To select these peptides, the
proﬁles of Kite and Doolittle (hydropathicity index)
and Chou and Fasman (secondary-structure predic-
tion) were used to determine E2 regions sharing both
partition into membranes and b-turn structure tenden-
cies. In this sense, the two selected E2 regions, in spite
of having Pro within their primary sequences, showed
different features. Thus, whereas E2(7–26) has a high
b-turn content but no membrane afﬁnity, the region of
E2 located between residues 279 and 298 has both pre-
dictive features.
The secondary structure of both peptides was meas-
ured by CD. We monitored several parameters that
determine peptide–membrane interaction, and com-
bined analysis of the data obtained provides insights
into HGV ⁄GBV-C–membrane interaction.
Results
The E2 peptides synthesized are amphiphilic because
of the presence of hydrophobic and hydrophilic amino
acids in their composition which make them water
soluble and able to associate with model membranes.
E2(7–26) (GSRPFEPGLTWQSCSCRANG) contains
two positively charged Arg residues (Arg9 and Arg23),
which could be important for the interaction with neg-
atively charged phospholipid membranes [14]. E2(279–
298) (AGLTGGFYEPLVRRCSELAG) is a neutral
peptide containing two positive arginines (Arg285,
Arg286) and two negatively charged amino acids
(Glu282, Glu290); it has an isoelectric point (pI) of
6.18 and a mean hydrophobicity (H0) of 0.13.
A Trp residue was incorporated at the N-terminus
of the wild E2(279–298) sequence to provide a suitable
chromophore for monitoring lipid–peptide interaction.
The presence of this Trp residue in W-E2(279–298)
modiﬁed neither the hydrophobicity (0.16) nor the pI
(6.14) of the parent E2(279–298) peptide.
Binding of E2 peptides to model membranes
Lipid interaction of the E2 peptides was studied by
monitoring Trp ﬂuorescence changes on titration of
peptide solutions with small unilamellar vesicles
(SUVs).
In Tris ⁄HCl buffer containing 150 mm NaCl, the
maximal Trp ﬂuorescence emission wavelength (kmax)
of the peptides was 347 and 350 nm for E2(7–26) and
W-E2(279–298), respectively. Our results show that, in
lipid-free peptides, Trp residues are highly exposed to
water.
To investigate the contribution of electrostatic inter-
actions, the peptides were titrated with both neut-
ral and negatively charged vesicles. Titration of the
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peptides with neutral 1-palmitoyl-2-oleoylphosphatidyl-
choline (PamOlePtdCho) SUVs resulted in no shift for
E2(7–26) and a shift of only 1 nm for W-E2(279–298).
Incubation of E2(7–26) peptide with negatively
charged vesicles, PamOlePtdCho ⁄ 1-palmitoyl-2-oleoyl-
phosphatidylglycerol (PamOlePtdGro) (75 ⁄ 25) and egg
PtdCho ⁄brain PtdSer (65 ⁄ 35), had little effect on the
Trp ﬂuorescence intensity of the peptide and did not
affect the shape of the Trp ﬂuorescence spectrum. Blue
shifts of 3 nm and 1 nm were found for this peptide
upon titration with 200 lm PamOlePtdCho ⁄Pam-
OlePtdGro (75 ⁄ 25) and 200 lm PtdCho ⁄PtdSer
(65 ⁄ 35). In contrast, addition of the negatively
charged vesicles to the E2(279–298) peptide shifted the
maximal Trp ﬂuorescence emission to lower wave-
lengths. The larger blue shift of 11 nm was measured
for the peptide titration with egg PtdCho ⁄brain PtdSer
(65 ⁄ 35). Blue shifts of this magnitude have been
observed when surface-active Trp-containing peptides
interact with lipid membranes and are consistent with
the Trp residue partition into a more hydrophobic
environment [15–19]. This also indicates that the Trp
residues are only partially buried in the vesicles, as a
moiety that is fully protected from water is expected
to have emission at  320 nm.
As a general rule, on titration with negatively
charged vesicles, Trp ﬂuorescence decreased and the
wavelength of maximal Trp ﬂuorescence shifted to
lower wavelengths. As an example, Fig. 1 shows the
curves of the peptides in buffer and in the presence of
PamOlePtdCho ⁄PamOlePtdGro SUVs.
The electrostatic interactions were further studied by
titration of the peptides with egg PtdCho ⁄brain PtdSer
(65 ⁄ 35) SUVs in Tris ⁄HCl buffer without salt. For
both peptides, the blue shift increased up to 14 and
15 nm for E2(7–26) and W-E2(279–298), respectively.
After titration with egg PtdCho ⁄brain PtdSer (65 ⁄35)
SUVs without salt, the blue shift was also accompanied
by a decrease in the Trp ﬂuorescence intensity. Plotting
the percentage of initial ﬂuorescence as a function of
the lipid concentration (Fig. 2) enabled calculation of
Kd values. For both peptides, the titration curves show
saturable binding. The afﬁnity for egg PtdCho ⁄brain
PtdSer (65 ⁄ 35) SUVs was higher for W-E2(279–298)
than for E2(7–26) [Kd was 67 ± 10 lm for E2(7–26)
and 31 ± 2.5 lm for W-E2(279–298)] (Table 1).
Finally, the effect of membrane rigidity was studied
using PamOlePtdCho ⁄PamOlePtdGro ⁄ cholesterol (45 ⁄
30 ⁄ 25) SUVs. The presence of cholesterol in the lipid
bilayer had a minor effect, as there was a shift in kmax
of 3 nm for E2(7–26) and 6 nm for W-E2(279–298).
Peptide conformation
In buffer, the CD spectra for the E2 peptides showed
the characteristics of a random-coil conformation, as
indicated by the presence of a negative band at
Fig. 1. Fluorescence emission spectra of the E2(7–26) (black bro-
ken line) and W-E2(279–298) (black solid line) peptides (2 lM) in
Tris ⁄HCl buffer (pH 8) ⁄ 0.15 mM NaCl (black) and in the presence of
0.2 mM PamOlePtdCho ⁄ PamOlePtdGro (75 ⁄ 25) SUVs (grey).
Fig. 2. Fluorescence titration curves of E2(7–26) (m), W-E2(279–
298) ( ) and penetratine(43–58) (d) with egg PtdCho ⁄ brain PtdSer
(65 ⁄ 35) SUVs without salt. Curve-fitting of the experimental data is
represented by solid lines.
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198 nm. In aqueous 2,2,2-triﬂuoroethanol solutions,
the percentage of a-helix in W-E2(279–298) increased,
whereas this was not the case for E2(7–26). In Fig. 3,
as an example, the CD spectra of E2 (279–298) in buf-
fer, in 50% (v ⁄v) triﬂuoroethanol, and in PamOlePtd-
Cho ⁄PamOlePtdGro (2 : 1) SUVs are shown. We can
observe the change to a more structured conformation
when the mimetic membrane solvent triﬂuoroethanol
or SUVs are added.
Incubation with mixed PamOlePtdCho ⁄PamOlePtd-
Gro (80 ⁄ 20) or PamOlePtdCho ⁄PamOlePtdGro ⁄ choles-
terol (50 ⁄ 25 ⁄ 25) SUVs increased the a-helix content of
W-E2(279–298) (Table 2). In contrast, the percentage
of b-type structure decreased. In all cases, E2(7–26)
remained mainly unstructured, even when bound to
phospholipid vesicles.
Acrylamide quenching
The accessibility of the Trp residues of the E2 pep-
tides to the neutral, water-soluble acrylamide quen-
cher was examined in the absence and presence of
phospholipid vesicles. Fluorescence of Trp decreased
in a concentration-dependent manner after the addi-
tion of acrylamide to the peptide solution in the
presence or absence of liposomes (data not shown).
Figure 4 shows the Stern-Volmer plots for acryl-
amide quenching of E2 peptides in buffer, and in the
presence of egg PtdCho ⁄brain PtdSer (60 ⁄ 40) SUV
vesicles. The Stern-Volmer quenching constants (Ksv)
of the lipid-free peptides were 13.6 ± 0.6 m)1 for
E2(7–26) and 26.6 ± 0.2 m)1 for W-E2(279–298)
(Table 1), indicating that the Trp residue of the pep-
tides was readily quenched by acrylamide. Incuba-
tion with egg PtdCho ⁄brain PtdSer (60 ⁄ 40) SUVs
decreased the Ksv values twofold for E2(7–26) and
3.7-fold for W-E2(279–298), showing in the latter case
that the Trp residues are more protected from the
quencher.
Quenching by brominated lipids
The depth of insertion of the Trp residues of E2 peptides
into lipid bilayers was estimated by dibromo-PtdCho
Table 1. Maximal Trp emission wavelength (k max) for lipid-free and lipid-bound E2(7–26), W-E2(279–298) and P(48–53) peptides, apparent
dissociation constants (Kd) for titration of the peptides with egg PtdCho ⁄ brain PtdSer (65 ⁄ 35) SUVs, and Stern–Volmer constants (Ksv) for
acrylamide quenching of Trp fluorescence of the peptides before and after incubation with egg PtdCho ⁄ brain PtdSer (60 ⁄ 40) SUVs. P(43–
58), Penetratine(43–58).
E2(7–26) W-E2(279–298) P(43–58)
kmax (nm)
Buffer 347 350 347
PamOlePtdCho 347 349 347
PamOlePtdCho ⁄ PamOlePtdGro (75 ⁄ 25) 344 342 337
PamOlePtdCho ⁄ PamOlePtdGro ⁄Chol (45 ⁄ 30 ⁄ 25) 344 344 339
Egg PtdCho ⁄ brain PtdSer (65 ⁄ 35) 346 339 338
Egg PtdCho ⁄ brainPS buffer no salt (65 ⁄ 35) 332 336 339
Kd (lM)
Egg PtdCho ⁄ brain PtdSer (65 ⁄ 35) 67 ± 10 31 ± 2.5 5.5 ± 0.1
Ksv (M
)1)
Buffer 13.6 ± 0.6 26.6 ± 0.2 18.6 ± 1.1
Egg PtdCho ⁄ brain PtdSer (60 ⁄ 40) 6.8 ± 0.2 7.2 ± 0.2 2.7 ± 0.1
Fig. 3. CD spectra of W-E2(279–298) (22 lM) in phosphate buffer,
pH 7.4 (black solid line), 50% trifluoroethanol (black broken line)
and PamOlePtdCho ⁄ PamOlePtdGro (80 ⁄ 20) SUVs (grey broken line).
CD spectrum of penetratine(43–58) in PamOlePtdCho ⁄ PamOle-
PtdGro (80 ⁄ 20) SUVs (grey solid line).
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quenching. Both peptides were quenched more efﬁ-
ciently by Br6,7-PtdCho than by Br11,12-PtdCho (Fig. 5),
suggesting that they remain close to the lipid ⁄water
interface. For both lipid quenchers, Trp quenching efﬁ-
ciency was higher for W-E2(279–298) than for E2(7–26),
indicating deeper insertion of W-E2(279–298) into the
membrane.
Membrane permeabilization
Figure 6 shows the calcein leakage out of egg Ptd-
Cho ⁄brain PtdSer (70 : 30) large unilamellar vesicles
(LUVs) induced by the E2 peptides. Leakage of 70%
was reached for E2(7–26) at a peptide to lipid ratio of
2 : 1. For W-E2(279–298), complete lysis of the LUVs
was reached at a peptide to lipid ratio of 1 : 1. For the
E2(7–26) peptide, a sigmoidal dose–response curve was
obtained, indicating peptide co-operativity, whereas
this was not the case for W-E2(279–298) (Fig. 6A).
Calcein leakage kinetics were faster for the W-E2(279–
298) peptide, which induced complete vesicle lysis after
15 min compared with 1 h for the E2(7–26) peptide
(Fig. 6B).
Table 2. a-Helical, b-structure and random coil content of the E2 peptides, as calculated using the K2D and CONTIN programs, and based on
the mean residue ellipiticity at 222 nm [33]. TFE, trifluoroethanol.
% a-Helix % b-Structure % Random oil
h222 K2D CONTIN b-Sheet (K2D) b-Sheet (K2D) b-Turn (CONTIN) K2D CONTIN
E2(7–26)
Buffer 13 8 12 41 27 24 50 37
25% TFE 15 9 12 36 32 22 55 34
50% TFE 18 14 16 30 29 23 42 33
PamOlePtdCho 11 7 9 51 34 23 50 36
PamOlePtdCho ⁄PG (80 ⁄ 20) 15 8 11 41 31 22 50 36
PamOlePtdCho ⁄PG ⁄Chol (50 ⁄ 25 ⁄ 25) 15 8 4 41 44 18 56 32
E2(279–298)
Buffer 15 10 13 34 16 16 56 55
25% TFE 33 10 14 36 17 14 55 55
50% TFE 34 28 37 15 14 16 58 33
PamOlePtdCho 20 33 37 16 20 14 50 28
PamOlePtdCho ⁄PG (80 ⁄ 20) 28 46 42 20 15 16 33 27
PamOlePtdCho ⁄PG ⁄Chol (50 ⁄ 25 ⁄ 25) 29 57 47 10 17 16 33 19
Fig. 4. Stern–Volmer plots for acrylamide quenching of E2(7–26)
(triangles), W-E2(279–298) (squares) and penetratine(43–58)
(circles). Filled symbols represent the peptides in aqueous buffer;
open symbols represent the peptides in the presence of 0.2 mM
egg PtdCho ⁄ brain PtdSer (60 ⁄ 40) SUVs.
Fig. 5. Trp quenching efficiency (F0 ⁄ F) of E2(7–26), W-E2(279–298)
and penetratine(43–58) peptides (2 lM) bound to egg PtdCho ⁄ brain
PtdSer (65 ⁄ 35) SUVs (lipid to peptide molar ratio 0.01) by Br6,7-Ptd-
Cho (grey bars) and Br11,12-PtdCho (black bars).
HGV ⁄GBV-C fusion peptide C. Larios et al.
2460 FEBS Journal 272 (2005) 2456–2466 ª 2005 FEBS
Vesicle aggregation
Incubation of egg PtdCho ⁄brain PtdSer (60 ⁄ 40) SUVs
with E2(7–26) peptide induced vesicle aggregation at a
0.2 peptide to lipid ratio, as indicated by the increase
in A436 (Fig. 7). In contrast, the W-E2(279–298) pep-
tide did not show any increase in A436.
Discussion
HGV ⁄GBV-C is the most closely related human virus
to HCV, both of them belonging to the small envel-
oped viruses of the Flaviviridae family. A stretch
of conserved, hydrophobic amino acids within the E2
envelope glycoprotein of HCV has been proposed as
the virus fusion peptide [8]. However, because of
the low pairwise sequence identity with HCV E2
(< 20%), it has not been feasible to select a stretch
of residues in the HGV ⁄GBV-C E2 protein, with
sequence homology to the highly conserved loop of the
ﬂavivirus E protein described as an internal fusion
peptide.
In this study we have analysed the interactions of an
N-terminal and an internal peptide sequence of the E2
structural protein of HGV ⁄GBV-C with model mem-
branes, in order to understand the possible mode of
penetration of HGV ⁄GBV-C into the membrane cells.
These synthetic peptides are characterized by the pres-
ence of Pro residues, which have been reported to play
important roles in membrane-inserted peptide chains,
speciﬁcally promoting kinks at the level of the mem-
brane interface. Moreover, they have a high content of
aliphatic hydrophobic residues, such as Val and Leu,
and aromatic hydrophobic residues (Tyr, Phe, Trp), as
well as the three small amino acids Gly, Ala, Thr. It
has been suggested that these particular amino-acid
contents may confer structural plasticity on these
peptides, which seems to be crucial for the fusion
process [20].
Fig. 6. (A) Calcein leakage induced by E2(7–26) (m) and
W-E2(279–298) ( ) from egg PtdCho ⁄ brain PtdSer (70 ⁄ 30) LUVs
as a function of peptide to lipid molar ratio. (B) Percentage of
leakage vs. time for E2(7–26) (m), W-E2(279–298) ( ), and melit-
tin (d). Peptide to lipid molar ratio 1 : 1 (E2 peptides) and 1 : 25
(melittin).
Fig. 7. Turbidity (A436) of dispersion of egg PtdCho ⁄ brain PtdSer
SUVs in the absence (solid line) and presence of the E2(7–26)
(black) and W-E2(279–298) (grey) peptides at 0.04 (broken line) and
0.2 (dotted line) peptide to lipid molar ratio.
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Although fusion peptides have been widely described
as short hydrophobic segments of viral envelope glyco-
proteins with a very low content of hydrophilic amino
acids, the presence of acidic residues in the fusion pep-
tides of some low-pH-activated viral fusion proteins
has been observed [21]. Moreover, it has been reported
that the putative internal fusion peptide of TBEV is
highly constrained by multiple interactions, including
several internal hydrogen bonds and salt bridges [22].
The analogue fusion peptide proposed for HCV is
characterized by a positively charged region, which has
been shown experimentally to be important for hetero-
meric association between envelope proteins E1 and
E2 [8]. Therefore, the presence of hydrophilic amino
acids in the fusion peptides of ﬂaviviruses seems to be
crucial for the fusion process.
We have investigated the ﬂuorescence properties of
the Trp residues of E2(7–26) and W-E2(279–298) pep-
tides in buffer as well as in the presence of neutral and
negatively charged vesicles. In lipid-free peptides, both
Trp residues are highly exposed to the aqueous phase,
suggesting a monomeric rather than aggregated struc-
ture. This was conﬁrmed by the extent of acrylamide
quenching. Moreover, CD measurements showed that
both peptides are randomly structured in buffer.
The addition of neutral lipid vesicles to the peptides
induced no blue shift of kmax, suggesting that the pep-
tides hardly interacted at all with PamOlePtdCho
SUVs. The E2(7–26) peptide titration with negatively
charged vesicles [PamOlePtdCho ⁄PamOlePtdGro
(75 ⁄ 25) and PtdCho ⁄PtdSer (65 ⁄35)] showed a slight
blue shift in Trp ﬂuorescence, suggesting a weak inter-
action between this sequence and negatively charged
SUVs. In contrast, W-E2(279–298) strongly interacted
with PtdCho ⁄PtdSer (65 ⁄ 35) vesicles, as the blue shift
of Trp was 11 nm.
To study the contribution of electrostatic inter-
actions to the binding of both peptides with negatively
charged SUVs, titration of the peptides with Ptd-
Cho ⁄PtdSer vesicles was carried out in the absence of
salt. The E2(7–26) peptide showed a signiﬁcantly
higher blue shift of Trp ﬂuorescence in buffer without
salt, whereas W-E(279–298) showed a similar ﬂuores-
cence spectrum to that obtained in 10 mm Tris ⁄HCl
buffer containing 0.15 m NaCl. These results suggest
that electrostatic interactions play a principal role in
the binding of E2(7–26) to negatively charged residues.
In contrast, a higher contribution of hydrophobic com-
pared with electrostatic interactions is expected to con-
trol the binding of W-E2(279–298) to PtdCho ⁄PtdSer
vesicles. This is supported by the vesicle aggregation
results induced on the addition of peptides to Ptd-
Cho ⁄PtdSer (60 ⁄ 40) SUVs. Thus, in contrast with
W-E2(279–298) peptide, the E2(7–26) sequence promo-
ted vesicle aggregation, conﬁrming that the binding of
this peptide to PtdCho ⁄PtdSer vesicles is mainly due to
electrostatic interactions.
Acrylamide and dibromo-PtdCho quenching experi-
ments were performed to estimate the depth of inser-
tion of the Trp residues of E2 peptides into lipid
bilayers. The Stern-Volmer quenching constants for
the PtdCho ⁄PtdSer-incubated peptides, as well as the
Trp quenching efﬁciency by brominated lipids, indica-
ted a deeper insertion of W-E2(279–298) into the mem-
brane than E2(7–26) peptide. Moreover, Br6,7-PtdCho
quenched the Trp residue in W-E2(279–298) more efﬁ-
ciently than Br11,12-PtdCho, suggesting that this pep-
tide remains close to the lipid ⁄water interface.
Cell membranes have an asymmetric distribution of
zwitterionic and negatively charged phospholipids char-
acterized by localization in the inner leaﬂet of the bi-
layer of the second one. In a previous study [14], it has
been suggested that the preferential interaction of the
synthetic peptides with anionic membranes may be rela-
ted to the fact that some membrane proteins, having
clusters of basic amino acids, require small amounts of
anionic lipids to interact with the cell membrane.
Induction of vesicle permeability on addition of pep-
tide fragments representing fusion peptide sequences
has been shown to correlate well with fusion peptide
functionality, in most instances. In this study, we com-
pared the ability of E2(7–26) and W-E2(279–298) to
induce leakage from PtdCho ⁄PtdSer (70 : 30) vesicles.
The calcein release induced by the peptides was
dependent on the concentration, so when a sufﬁcient
high concentration of the peptides is reached, a larger
aggregated form could induce the membrane permeab-
ility. The W-E2(279–298) peptide showed signiﬁcantly
higher leakage activity than E2(7–26), as the former
was able to induce extensive efﬂux of aqueous contents
into the medium at a peptide to lipid molar ratio two
times lower. This vesicle permeabilization process
appears to be mediated by the peptide conformation
adopted in membranes. CD experiments showed that
the addition of 50% triﬂuoroethanol or negatively
charged vesicles induced a-helical conformation in the
W-E2(279–298) peptide. However, the E2(7–26) pep-
tide conformation in a membraneous environment
remained random coil like.
The data together suggest that the E2(7–26) peptide is
hardly transferred at all from water to the membrane
interface, as it mainly interacts electrostatically with the
vesicle surface. In contrast, the W-E2(279–298) peptide
is able to penetrate into negatively charged bilayers
remaining close to the lipid ⁄water interface. This non-
polar environment induces a peptide structural transi-
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tion from random coil to a-helix, causing bilayer pert-
urbations that lead to vesicle permeabilization.
In summary, our data suggest that the internal
region (279–298) of the E2 structural protein may be
involved in the fusion process of HGV ⁄GBV-C.
Experimental procedures
Materials
Egg yolk PtdCho, brain PtdSer, PamOlePtdCho, PamOlePtd-
Gro, 1-palmitoyl-2-stearoyl-(6–7)dibromo-sn-glycero-3-pho-
sphocholine (Br6,7-PtdCho) and 1-palmitoyl-2-stearoyl-(11–
12)dibromo-sn-glycero-3-phosphocholine (Br11,12-PtdCho)
were from Avanti Polar Lipids (Alabaster, AL, USA).
Calcein was from Fluka (Bucks, Switzerland). Rink amide
MBHA and Novasyn TGR resins, amino-acid derivatives
and coupling reagents were obtained from Fluka and
Novabiochem (Nottingham, UK). Dimethylformamide was
purchased from Sharlau (Barcelona, Spain). Triﬂuoroacetic
acid was supplied by Merck (Poole, Dorset, UK) and scav-
engers such as ethanedithiol and tri-isopropylsilane were
from Sigma-Aldrich (Steinheim, Germany).
Peptide synthesis
The peptides were synthesized manually following proce-
dures described previously [23,24]. The syntheses were
carried out by solid-phase methodology following an
Fmoc ⁄ tBu strategy with a N,N¢-di-isopropylcarbodiimide ⁄
1-hydroxybenzotriazole activation. For the incorporation
of Cys293 into the E2(279–298) and W-E2(279–298)
peptides, repeated coupling using 2-(1H-benzotriazol-
1-yl)-1,1,3,3-tetramethyluronium tetraﬂuoroborate and
N,N¢-di-isopropylethylamine as activators was needed.
Threefold molar excesses of Fmoc-amino acids were used
throughout the synthesis. The stepwise addition of each
residue was determined by Kaiser’s test [25]. Peptides were
cleaved from the resin with a triﬂuoroacetic acid solu-
tion containing appropriate scavengers (either water and
1,2-ethanedithiol or water, tri-isopropylsilane ethanedi-
thiol), and puriﬁed by HPLC on a semipreparative C18
kromasil column. The samples were eluted with a lin-
ear gradient of acetonitrile in an aqueous solution of
0.05% triﬂuoroacetic acid. Puriﬁed peptides were checked
by analytical HPLC in an analytical C18 kromasil column,
MALDI-TOF MS, and amino-acid analysis. Peptides were
lyophilized and stored at 4 C.
Positive control peptides
Penetratine(43–58) [26] and melittin [27] were used as positive
control peptides throughout all the experimentation carried
out. Penetratine(43–58) was used as a control in binding to
SUVs, acrylamide quenching, brominated phospholipid
quenching, and CD experiments. Melittin was used as a
control in the leakage experiments.
Vesicle preparation
Lipid ﬁlms were prepared by dissolving the phospholipids in
a chloroform ⁄methanol (2 ⁄ 1, v ⁄ v) solution, followed by sol-
vent evaporation under a ﬂow of nitrogen and overnight
vacuum. Multilamellar vesicles were obtained by vortex mix-
ing of the lipid ﬁlms in 10 mm Tris ⁄HCl buffer, pH 8.0, con-
taining 0.15 m NaCl for 10 min above the phase transition
temperature. On the one hand, SUVs were then obtained by
sonication of the multilamellar vesicles at 4 C using a
Sonics Material Vibra-CellTM sonicator. Titanium debris
was removed by centrifugation. SUVs were separated from
multilamellar vesicles by gel ﬁltration on a Sepharose CL 4B
column. The top fractions of the SUVs peak were pooled,
concentrated and stored at 4 C. On the other hand, LUVs
were prepared by freeze-thawing the multilamellar vesicles in
liquid nitrogen (15 times) [28], and extrusion through two
stacked 100-nm polycarbonate ﬁlters (15 times; Nucleopore,
Pleasanton, CA, USA) in a high-pressure extruder (Lipex
Biomembranes, Vancouver, Canada) and stored at 4 C.
PtdCho concentration was determined by an enzymatic
colorimetric assay (bioMe´rieux), and total phospholipid
concentration was determined by phosphorus analysis [29].
Trp fluorescence titrations
Fluorescence titrations were performed on an Aminco Bow-
man series 2 spectroﬂuorimeter, equipped with a thermo-
statically controlled cuvette holder (22 C). Fluorescence
emission spectra of 2 lm peptide solutions in 10 mm
Tris ⁄HCl containing 0.15 m NaCl, pH 8.0, in either the
absence or presence of lipids, were recorded between
310 nm and 450 nm, with an excitation wavelength of
290 nm, at a slit width of 4 nm. The ﬂuorescence spectra
were instrument corrected for light scattering, by subtract-
ing the corresponding spectra of the SUVs.
Changes in Trp ﬂuorescence were used to evaluate pep-
tide-lipid binding. The apparent dissociation constants were
calculated from plots of the ﬂuorescence intensity at
350 nm, expressed as the percentage of the ﬂuorescence of
the lipid-free peptides vs. the added lipid concentration.
The data were analysed using Graphpad software, by
means of the following equation:
F ¼ fF0 þ F1ð1=KdÞ½Ltotg=f1þ ð1=KdÞ½Ltotg ð1Þ
where F is the ﬂuorescence intensity at a given added lipid
concentration, F0 the ﬂuorescence intensity at the beginning
of the titration, F1 the ﬂuorescence at the end of the titra-
tion, Kd the dissociation constant, and [Ltot] the total lipid
concentration [30].
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CD measurements
CD was measured on a Jasco 710 spectropolarimeter
(Hachioji, Tokyo, Japan) between 184 and 260 nm in a
quartz cell with a path length of 0.1 cm. Nine spectra were
recorded and averaged. The spectra of the lipid-free
peptides were measured in sodium phosphate buffer
(50 mgÆmL)1) or in the presence of increasing percentages
of triﬂuoroethanol (25%, 50%, 75%). CD spectra of lipid-
bound peptides at peptide to lipid molar ratios of 1 : 20 or
1 : 40 were recorded after 1 h incubation at room tempera-
ture. The spectra were corrected by subtraction of the spec-
trum of the SUVs alone {results are expressed as mean
residue ellipticities [h]MR (degree.cm
2Ædmol)1)}. The secon-
dary structure of the peptides was obtained by curve-ﬁtting,
using the K2D and Contin programs by the Dichroweb
server at http://www.cryst.bbk.ac.uk7cdweb [31,32]. The
helical content of the peptides was also calculated from the
mean residue ellipticity at 222 nm [33].
Acrylamide quenching experiments
For acrylamide quenching experiments, an excitation wave-
length of 290 nm was used. Aliquots of the water–soluble
acrylamide (10 m stock solution) were added to 2 lm pep-
tide in 10 mm Tris ⁄HCl buffer, pH 8.0, in the absence or
presence of SUVs. The lipid ⁄ peptide mixtures (molar ratio
50 : 1) were incubated for 30 min at room temperature
before the measurements. Fluorescence intensities at
350 nm were monitored after each acrylamide addition at
25 C. The values obtained were corrected for dilution, and
the scatter contribution was derived from acrylamide titra-
tion of a vesicle blank. Ksv, which is a measure of the acces-
sibility of Trp to acrylamide, was obtained from the slope
of the plots of F0 ⁄F vs. [quencher], where F0 and F are the
ﬂuorescence intensities in the absence and presence of quen-
cher, respectively [18,34]. As acrylamide does not partition
signiﬁcantly into membrane bilayers, the value of Ksv can
be considered the fraction of the peptide residing in the
surface of the bilayer as well as the amount of nonvesicle-
associated free peptide.
Brominated lipid quenching experiments
Quenching of Trp by brominated phospholipids was per-
formed to ﬁnd the localization of this residue in bilayers
[35,36]. Peptides (2 lm) were incubated for 30 min at
22 C with a 50-fold molar excess of lipids in 10 mm
Tris ⁄HCl buffer, pH 8. Emission spectra were recorded
between 310 and 450 nm with an excitation wavelength of
290 (± 4 nm). The quenching efﬁciency (F0 ⁄F) was calcu-
lated by dividing the Trp ﬂuorescence intensity of the
peptide in the presence of egg PtdCho ⁄brain PtdSer
(60 ⁄ 40) SUVs (F0), by the Trp ﬂuorescence intensity of
the peptide in the presence of dibromo-PtdCho ⁄ brain
PtdSer (70 ⁄ 30) SUVs (F). F0 ⁄F was compared for
quenching by Br6,7-PtdCho and Br11,12-PtdCho lipid-phase
quenchers.
Assay of calcein leakage
Dequenching of encapsulated calcein ﬂuorescence resulting
from the leakage of aqueous content out of LUVs was used
to assess the vesicle leakage activity of the peptides. LUVs
containing calcein were obtained by hydration of the dried
ﬁlm in 10 mm Tris ⁄HCl buffer, pH 8.0, containing 70 mm
calcein. LUVs were prepared as described above, and non-
encapsulated calcein was removed by gel ﬁltration on a
Sephadex G-100 column. Calcein leakage out of LUVs
(50 lm lipids) was measured after 15 min incubation at
22 C in the same buffer as was used for the ﬂuorescence
titrations. Calcein ﬂuorescence was measured at 520 nm,
with an excitation of 490 nm and slit widths of 4 nm, of a
50-fold diluted 20 lL sample of the peptide ⁄ lipid incuba-
tion mixture containing 50 lm lipids. Leakage (%) was cal-
culated using the following equation:
% Leakage ¼ ð½F  F0=½F100  F0Þ  100 ð2Þ
where F0 is the ﬂuorescence intensity of LUVs alone, F, the
ﬂuorescence intensity after incubation with the peptide, and
F100, the ﬂuorescence intensity after the addition of 10 lL
5% (v ⁄ v) Triton X-100.
Assay of vesicle aggregation
The ability of the peptides to induce vesicle aggregation
was studied by monitoring the turbidity of a SUV suspen-
sion of egg PtdCho ⁄ brain PtdSer (60 ⁄ 40) (50 lm) at
436 nm over 1 h (22 C) on an Uvikon 941 spectropho-
tometer (peptide lipid to molar ratios of 0.2 and 0.04).
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